News & Articles

The COVID-19 vaccine trial is part of a global development program that will uncover the safety and immunogenicity of four mRNA vaccine candidates.

Test deployed on Quanterix' Simoa platform promises 1,000-fold sensitivity improvement

Science industry comes together online to share knowledge and provide technology solutions for cancer and immunology research

Assay will help guide treatment decisions in cases of non-small cell lung cancer

The company says it continues to optimize its coronavirus test amid questions about its accuracy

Collaboration with WuXi Diagnostics and Mayo Clinic on serology test will complement Thermo Fisher's widely adopted TaqPath COVID-19 molecular diagnostic test

The digital tool could help simplify the screening, diagnosis and monitoring of patients with respiratory compromise in the current COVID-19 pandemic

The Alinity m molecular laboratory COVID-19 test instrument claims it can run up to 1,080 tests in 24 hours

A research team at the University of Cambridge has designed a ventilator for treating COVID-19 patients that can be quickly and cheaply manufactured

Thermo Fisher Scientific will provide 50 Ion Torrent Genexus Systems for consortia members to support global COVID-19 research

New Ion AmpliSeq SARS-CoV-2 Research Panel assists with contact tracing to identify coronavirus hot spots

Clinical laboratories certified to perform high complexity tests under Clinical Laboratory Improvement Amendments (CLIA) can immediately begin using this ELISA

Register today to reserve a place at the Summit - it opens at 13:00 (BST) / 14:00 (CEST) / 08:00 (EDT) / 05:00 (PDT) on Monday, May 11

AMSBIO's new service utilizes their novel lentiviral system to aid the development of therapeutic drugs and vaccines

Preliminary results from a government-sponsored study suggest that drug used to treat Ebola may help COVID-19 patients

Innovosens building partnerships to accelerate development, testing and market launch

The blood-based immunoassay test enables clinicians to identify the virus linked with COVID-19

The serology test promises 100% sensitivity and can help assess patients' immune response to the virus

The molecular test kit promises 100% diagnostic sensitivity and specificity, and is authorized for clinical practice use in Europe

The company aims to provide solutions for the pandemic through close collaboration with scientists and providing cutting-edge laboratory equipment

Learn more about how BINDER is helping countless laboratories across the world conduct research into coronavirus.

Collaboration will enable global development, manufacturing and distribution of the vaccine

The test will be available for qualified laboratories across the European Union by the end of May

Comprehensive turnkey system based on LabVantage LIMS platform allows laboratories to implement COVID-19 Biobanking, testing and research

Pioneering new class of diagnostic product will transform fight against pandemic